Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UK working with U.S., WTO on boosting COVID vaccine supply - spokesman

Thu, 06th May 2021 11:52

LONDON, May 6 (Reuters) - Britain is discussing ways of
increasing production and supply of COVID-19 vaccines with the
United States and World Trade Organization, a government
spokesperson said on Thursday after Washington supported waiving
their intellectual property rights.

"The UK is working with WTO members to resolve this issue.
We are in discussions with the U.S. and WTO members to
facilitate increased production and supply of Covid-19
vaccines," the spokesman said.

"As one of the biggest donors to COVAX, we will ensure
global access to vaccines and continue to encourage
manufacturers to provide their vaccines on a not-for-profit,
transparent basis."
(Reporting by Elizabeth Piper, editing by Michael Holden)

Related Shares

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.